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ABSTRACT 
Protein aggregation is a major factor limiting the biotechnological and therapeutic application of many 
proteins, including enzymes and monoclonal antibodies. The molecular principles underlying 
aggregation are by now sufficiently understood to allow rational redesign of natural polypeptide 
sequences for decreased aggregation tendency, and hence potentially increased expression and 
solubility. Given that aggregation prone regions tend to contribute to the stability of the hydrophobic 
core or to functional sites of the protein, mutations in these regions have to be carefully selected in 
order not to disrupt protein structure or function. Therefore, we here provide access to an automated 
pipeline to identify mutations that reduce protein aggregation by reducing the intrinsic aggregation 
propensity of the sequence (using the TANGO algorithm), while taking care not to disrupt the 
thermodynamic stability of the native structure (using the empirical force field FoldX). Moreover, by 
providing a plot of the intrinsic aggregation propensity score of aggregation prone regions corrected 
by the local stability of that region in the folded structure, we allow users to prioritise those regions in 
the protein that are most in need of improvement through protein engineering. The method can be 
accessed at http://solubis.switchlab.org/. 
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INTRODUCTION 
Protein aggregation is mediated by short aggregation prone regions (APRs), which assemble by 
intermolecular b-structured interactions that form the core of the aggregate. In native globular proteins 
these stretches are generally part of the hydrophobic core of the protein and hence protected from 
aggregation by the thermodynamic stability of the protein structure (Figure 1A). Besides structural 
stabilization a number of other mechanisms can also contribute to suppress aggregation (Balch et al., 
2008). One of them is the presence of aggregation gatekeeper residues, i.e. generally charged 
residues or prolines residues that slow down the aggregation reaction (Monsellier and Chiti, 2007, 
Otzen et al., 2000, Richardson and Richardson, 2002, Rousseau et al., 2006). In natural proteins 
sequences such gatekeeper residues are strongly enriched at the flanks of APRs. Moreover, 
molecular chaperones, such as Hsp70, bind to exposed APRs, preventing intermolecular assembly of 
APRs to nucleate aggregation (Van Durme et al., 2009). Finally, protein turnover rates (De Baets et 
al., 2011) and protein expression levels (Tartaglia et al., 2009) are also tuned to minimize protein 
aggregation under physiological conditions. However, not all proteins are folded or adopt a globular 
conformation under physiological conditions to exert their function. These intrinsically disordered 
proteins (IDP) are characterized by a high structural flexibility but do perform key regulatory functions 
(i.e. signaling activities, DNA and RNA binding and cell cycle control). Therefore in IDPs the structural 
stabilization of APRs cannot significantly contribute to the reduction of protein aggregation. Therefore 
several specific sequence adaptations are present to maintain their solubility and prevent aggregation: 
IDPs have a high net charge, low hydrophobicity (Uversky, 2002), a lower number of APRs (Linding 
et al., 2004), a higher proline content (Tompa, 2002) as well as the presence of so-called entropic 
bristle sequences (Santner et al., 2012). 
Aggregation of both globular proteins and IDPs have been associated with several pathologies, 
including neurodegenerative disorders such as Alzheimer’s Disease (amyloid-β) and Parkinson’s 
Disease (α-synuclein) (Ross and Poirier, 2004), as well as cancer (p53) (Xu et al., 2011) and 
metabolic diseases (a-Galactosidase) (Siekierska et al., 2012, Soong et al., 2009). In the case of 
globular proteins, the aggregation problem is often exacerbated through mutations, which increase 
the solvent exposure of the aggregation prone regions by thermodynamically destabilizing the native 
structure (Dobson, 2004). 
When globular proteins are employed for research, therapy or industrial applications, they need to 
withstand artificial conditions for which evolution has poorly equipped them. Given the ubiquitous 
nature of aggregation-prone sequences in the proteome, it is not surprising that protein aggregation is 
often observed when proteins are expressed far beyond their normal concentration in conditions with 
no or insufficient molecular chaperones. Moreover in technological applications, once purified, the 
proteins are expected to last far beyond their natural lifetime, allowing for critical nucleating events to 
start the protein aggregation reaction. Several methods have been developed to reduce protein 
aggregation of recombinant proteins, for example by using cell lines with increased chaperone 
content (Schlieker et al., 2002), by generating fusion proteins with solubilizing tags (Park et al., 2008, 
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Song et al., 2011, Zhang et al., 2004) or by careful formulation of buffers (Wang, 1999). Another 
approach would be to adapt the primary sequence to the new requirements through carefully selected 
mutations. We here present a webserver implementing a rational design strategy, called the Solubis 
(Ganesan et al., 2016), which employs the FoldX (Schymkowitz et al., 2005) and TANGO 
(Fernandez-Escamilla et al., 2004) algorithms to identify selected mutations that render a protein less 
aggregation-prone, while maintaining or even improving its intrinsic stability and function (Ganesan, 
Siekierska, Beerten, Brams, Van Durme, De Baets, Van der Kant, Gallardo, Ramakers, Langenberg, 
Wilkinson, De Smet, Ulens, Rousseau and Schymkowitz, 2016). 
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RESULTS 
The interplay between protein stability and intrinsic aggregation propensity  
Over 80% of proteins possess at least one APR in their primary sequence (Rousseau et al., 2006), 
but most often they form an integral part of the hydrophobic core of the protein (De Baets et al., 2014) 
and are thus protected from higher order interactions. Notable exceptions are active site and protein-
protein interaction sites, where functional constraints result in APRs in solvent exposed parts of the 
structure (Castillo and Ventura, 2009, Kumar et al., 2011, Wang et al., 2010). Therefore, when 
considering protein aggregation under native conditions, it is key to estimate the likelihood of each 
APR in the protein to become solvent exposed and thus available for aggregation with the identical 
sequence in other molecules. To achieve this, Trout et al have proposed to correct the hydrophobicity 
of each amino acid by the fraction of surface that is solvent exposed (Voynov et al., 2009). However, 
this method has two limitations: (i) it has long been known that beta-sheet propensity and local net 
charge are equally important determinants of local aggregation propensity (Chiti et al., 2003) and (ii) 
the degree of solvent exposure in the crystal structure underestimates the exposure of APRs through 
local unfolding/dynamics (Chiti and Dobson, 2009). To address these issues, we use (1) the TANGO 
algorithm to identify genuine APRs and to score the intrinsic aggregation propensity of the unfolded 
protein sequence and (2) use the empirical all-atom force-field FoldX to estimate the contribution of 
each APR to the local stability of the protein (DG value) (Schymkowitz, Borg, Stricher, Nys, Rousseau 
and Serrano, 2005). We display the total aggregation propensity of a protein using so-called stretch 
plots, where each APR is represented as a single point in a two-dimensional space where the intrinsic 
aggregation propensity of the region is on the ordinate and its contribution to protein stability is on the 
abscissa (Figure 1B). In this plot, the APRs are more problematic as they move towards to upper right 
corner of the plot. In order to be able to rank the aggregation of protein variants we also developed 
the Solubis score which allows capturing the information of the stretch-plot by a single numeral. The 
Solubis score results from calculating the summed DG of the APR, which is cut off between -5 and 5 
and rescaled to values between 0 and 1. For each residue, this value is multiplied by the TANGO 
score, resulting in the Solubis score. (Figure 1C). In this manner, the TANGO score of the most buried 
APRs is reduced, thereby eliminating these as determinants of aggregation nucleation under native 
conditions. As illustrated in the plots, the Protective Antigen protein of Bacillus antracis has different 
APRs identified in its sequence (Figure 1A&B), but only one seems particularly important under native 
conditions according to Solubis (Figure 1C). The importance of this stretch has previously been 
demonstrated experimentally (Ganesan et al., 2012). Moreover, it has also been experimentally 
demonstated that mutations in this stretch lead to a reduction of the aggregation of Protective antigen 
can be identified using the Solubis approach by scanning the Mutational Aggregation and Stability 
Spectrum of this APR, Figure 1D, see below). Mutant PA containing such a mutation was 
demonstrated to display significantly decrease aggregation kinetics at mildly elevated temperatures 
(40 °C, Figure 1E) while retaining its native structure and function (Ganesan, Siekierska, Beerten, 
Brams, Van Durme, De Baets, Van der Kant, Gallardo, Ramakers, Langenberg, Wilkinson, De Smet, 
Ulens, Rousseau and Schymkowitz, 2016) . 
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The Solubis Pipeline 
Protein aggregation nucleating regions can be identified using specialised software, which has been 
reviewed elsewhere (Belli et al., 2011, De Baets et al., 2014). We here employed the statistical 
thermodynamics algorithm TANGO (Fernandez-Escamilla, Rousseau, Schymkowitz and Serrano, 
2004) to detect aggregation hotspots in the target sequence. This algorithm was demonstrated to 
have the highest specificity in a recent independent comparison of aggregation predictors, resulting in 
a low number of false positives (Tsolis et al., 2013). For the purpose of guiding the design of 
mutations that will be experimental verified, this is an attractive feature since it maximises the chance 
that mutations actually reduce the aggregation tendency. The downside of this choice is a relatively 
low sensitivity, compared to other predictors (e.g. Aggrescan (Conchillo-Sole et al., 2007) or the 
metapredictor Amylpred2 (Tsolis, Papandreou, Iconomidou and Hamodrakas, 2013)), which can 
result in the failure to detect some APRs. Therefore, as protein solubility correlates with the number of 
APRs in a protein (Ganesan, Siekierska, Beerten, Brams, Van Durme, De Baets, Van der Kant, 
Gallardo, Ramakers, Langenberg, Wilkinson, De Smet, Ulens, Rousseau and Schymkowitz, 2016), 
reducing the aggregation propensity of APRs predicted with high specificity to contribute to 
aggregation under native conditions, is probably the most robust method to reduce aggregation.  
As it is important to consider mutations that reduce intrinsic aggregation without thermodynamically 
destabilising the native structure, we select proteins for which high-resolution crystallographic 
structures are available. Moreover, this structural information also enables us to visualize the 
topological position of the aggregating regions using atomic structure viewers. Methods that have 
reasonable accuracy in predicting the mutational effects on protein stability have been reviewed 
elsewhere (Potapov et al., 2009) and the results shown here were obtained exclusively with the FoldX 
forcefield (Schymkowitz, Borg, Stricher, Nys, Rousseau and Serrano, 2005), which shows excellent 
performance in protein redesign (Kiel and Serrano, 2014, McKeone et al., 2014).  
Two classes of mutations can be designed to reduce protein aggregation: (i) mutations that eliminate 
or strongly reduce the intrinsic aggregation propensity of the sequence, thereby slowing down the 
aggregation reaction and (ii) mutations that stabilise the interaction of the aggregating region with the 
rest of the structural domain in which it resides, thus providing additional protection from solvent 
exposure. In the ideal case, mutations can be identified that unify both goals, but often a combination 
of mutations is required to maximally suppress aggregation. Reduction of intrinsic aggregation is 
usually achieved by the introduction of aggregation breaking residues, called gatekeepers (Monsellier 
and Chiti, 2007, Rousseau, Serrano and Schymkowitz, 2006), in the aggregation nucleating 
sequences. Since the gatekeepers consist of the charged amino acids (Arg, Lys, Glu, Asp) and 
proline, most often they need to be placed in loop regions in order not to disturb the hydrophobic core 
of the protein. The Solubis method thus consists of systematically mutating the residues residing 
within an APR (or TANGO zone) to each of the gatekeeper residues and calculating the consequent 
change in TANGO score as well as the change in the thermodynamic stability of the protein using 
FoldX (this process will be called gatekeeper scan in what follows). The results of a computational 
gatekeeper scan of each APR can be displayed as a scatter plot (Figure 1D) of the change in 
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thermodynamic stability (DDG values calculated by FoldX in kcal/mol) versus change in the intrinsic 
aggregation propensity. The latter values are calculated by TANGO and range between 0 and 100 per 
amino acid residue. In the plot the sum of TANGO scores of all residues in a given APR is given. 
These Mutant Aggregation & Stability Spectrum (MASS) plots (Siekierska et al., 2012) allow easy 
identification of ideal mutations, which have large negative values on both axes. This approach has 
been experimentally validated by improving the solubility and abundance of both protective antigen 
and a-galactosidase (Ganesan, Siekierska, Beerten, Brams, Van Durme, De Baets, Van der Kant, 
Gallardo, Ramakers, Langenberg, Wilkinson, De Smet, Ulens, Rousseau and Schymkowitz, 2016). 
Moreover, a survey of published solubility-increasing variants shows that 75% of the variants lower 
the aggregation tendency, illustrating the relevance of this method (De Baets et al., 2015). 
Solubis database 
Currently the database contains data on 74000 mutations analysed in 585 high-quality structures 
(sequence identity < 30%, R-factor < 0.19 and resolution < 1.5 Å) (Joosten et al., 2011) on which the 
Solubis approach was run. The database interface allows users to search for mutations by filtering on 
UniProtID, PDB ID, mutated residue (P, R, K, D or E) and the phenotypic effects. These effects 
include changes in aggregation tendency (DTANGO) and structural stability (DDG) upon mutation. 
Applying the filter settings results in a set of variants that fulfil the requirements. 
Job Submission and results viewing 
The Solubis website is free and open to all users and there is no login requirement. The execution 
time can range from a few minutes to about an hour. This depends on the number of APRs present in 
the protein, the type of selected gatekeepers and the size of the protein.	 In the following, a description 
of the required input and the output are given in more detail.  
Input interface- In a first step, users need to define the structure they want to optimize either by 
providing a PDB ID or an uploaded PDB file. After selecting the chain they want to analyze; users can 
define the TANGO threshold i.e. the value above which a short stretch is treated as an aggregation 
prone region. All the defined APRs will be analyzed by the Solubis approach, meaning that the higher 
this threshold, only the stronger APRs will be used for a Solubis analysis. As a last step, users need 
to select the gatekeeper residues to mutate the TANGO zone residues to. You can choose to mutate 
to all gatekeeper residues (P, R, K, D and E) or select only specific ones. 
Output- The Solubis output contains an overview of the identified APRs, which is represented by the 
above-described stretch plot (Figure 1B), where the intrinsic aggregation propensity of each APR is 
plotted against the contribution of this stretch to protein stability and a plot of the DG-rescaled TANGO 
aggregation propensity versus the primary sequence. Moreover, the aggregation-prone regions are 
also visualized in the original protein structure (Figure 1B). These plots illustrate in a clear way the 
location of aggregate prone regions in the protein and allow the user to identify the problematic APRs 
under native conditions. 
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For each of these APRs, a mutation scan to the selected gatekeepers is performed. The effect of 
these mutations on thermodynamic stability and intrinsic aggregation propensity is visualized in an 
above-described MASS-plot (Figure 1D) per APR, allowing the user to identify interesting mutations to 
modulate each relevant APR. We also offer a tab-delimited file containing an overview of all the 
mutations performed.  
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SUMMARY 
Over 80% of the proteome has at least one aggregation prone region within its primary sequence. As 
a result, protein aggregation is often encountered when proteins are overexpressed or recombinantly 
produced. Moreover, aggregation represents a major liability with respect to the immunogenicity of 
biotherapeutics. However, redesigning globular proteins to eliminate aggregation is not a 
straightforward task, as most aggregation nucleating sequences are part of the hydrophobic core and 
therefore difficult to mutate without disrupting protein structure and function. 
We developed a minimal redesign method, termed Solubis, to abrogate aggregation by silencing 
aggregation nucleating sequences with single point mutations, which are selected to maximally 
reduce the intrinsic aggregation propensity of the sequence whilst preserving thermodynamic stability 
of the functional protein. Our in silico method allows sifting hundreds to thousands of mutations, 
simultaneously evaluating protein aggregation and stability, typically detecting 1 to 5 appropriate 
aggregation-reducing mutations per target protein that are compatible with the native protein structure 
and stability. 
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FIGURE CAPTION 
Figure 1: Solubis analysis of the Protective Antigen protein from Bacillus Anthracis. A) 
Visualization of the APRs identified by TANGO in the protein structure (PDBID: 1ACC). B) Stretch plot 
where each point represents the intrinsic aggregation propensity and contribution to protein stability of 
a specific APR. The upper right corner represent exposed APRs with a high aggregation tendency. C) 
Plot of the normal TANGO aggregation propensity (TANGO) and the DG-rescaled TANGO 
aggregation propensity (SolubiS) versus the primary sequence. D) Mutant Aggregation and Stability 
Spectrum (MASS) plot visualizing the effect of each mutation on the change in thermodynamic 
stability (DDG) versus the change in intrinsic aggregation propensity (DTANGO). (E) Aggregation 
kinetics of protective antigen wild type (red) and solubis mutant T576E/S559L at 40°C measured by 
right angle light scattering at 475nm using the OPTIM1000 (Unchained labs) (Reproduced with 
permission from the authors from (Ganesan, Siekierska, Beerten, Brams, Van Durme, De Baets, Van 
der Kant, Gallardo, Ramakers, Langenberg, Wilkinson, De Smet, Ulens, Rousseau and Schymkowitz, 
2016)) 
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